María José Larráyoz
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 27
- Acute Myeloid Leukemia Research 21
- Chronic Myeloid Leukemia Treatments 8
- Multiple Myeloma Research and Treatments 3
-
- Protein Degradation and Inhibitors 6
- Co-authors
- Marı́a José Calasanz (34 shared papers)Xabier Agirre (12 shared papers)J.L. Vizmanos (9 shared papers)María D. Odero (14 shared papers)Francisco J. Novo (6 shared papers)Idoya Lahortiga (11 shared papers)M. García‐Delgado (3 shared papers)Juan C. Cigudosa (8 shared papers)
- Journals
- Blood (5 papers)Haematologica (4 papers)Leukemia (3 papers)Genes Chromosomes and Cancer (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
María José Larráyoz
33 papers receiving 791 citations
Peers
Comparison fields: 5 of 55
- Hematology 397
- Genetics 244
- Dermatology 81
- Rheumatology 95
- Molecular Biology 363
Countries citing papers authored by María José Larráyoz
This map shows the geographic impact of María José Larráyoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María José Larráyoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María José Larráyoz more than expected).
Fields of papers citing papers by María José Larráyoz
This network shows the impact of papers produced by María José Larráyoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María José Larráyoz. The network helps show where María José Larráyoz may publish in the future.
Co-authors
The 25 scholars most cited alongside María José Larráyoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 105 | |
| 2 | 2003 | 65 | |
| 3 | 2003 | 55 | |
| 4 | 2012 | 52 | |
| 5 | 2004 | 48 | |
| 6 | 2013 | 42 | |
| 7 | 2011 | 39 | |
| 8 | 2004 | 36 | |
| 9 | 2013 | 35 | |
| 10 | 2004 | 35 | |
| 11 | NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15). | 2003 | 32 |
| 12 | 2020 | 31 | |
| 13 | 2005 | 26 | |
| 14 | 2012 | 26 | |
| 15 | 2003 | 24 | |
| 16 | 2017 | 23 | |
| 17 | 2004 | 23 | |
| 18 | 2009 | 20 | |
| 19 | 2019 | 18 | |
| 20 | 2015 | 13 |
About María José Larráyoz
María José Larráyoz is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 806 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Protein Degradation and Inhibitors (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (397 citations), Genetics (244 citations), Dermatology (81 citations), Rheumatology (95 citations) and Molecular Biology (363 citations). María José Larráyoz has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Marı́a José Calasanz, Xabier Agirre, J.L. Vizmanos, María D. Odero, Francisco J. Novo, Idoya Lahortiga, M. García‐Delgado, Juan C. Cigudosa, Nicholas C.P. Cross and Iria Vázquez. Their work appears in journals such as Blood, Haematologica, Leukemia, Genes Chromosomes and Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.